The role of microRNAs in bone remodeling

International Journal of Oral Science

Volumn 7, Issue 3, 2015, Pages 131-143

  Jing, Dian ^a   Hao, Jin ^a   Shen, Yu ^a   Tang, Ge ^a   Li, Mei Le ^a   Huang, Shi Hu ^a,b   Zhao, Zhi He ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone remodeling; MicroRNAs; Osteoclastogenesis; Osteogenesis

Indexed keywords

MICRORNA;

ANIMAL; BONE REMODELING; CELL LINEAGE; CYTOLOGY; GENETIC TRANSCRIPTION; HUMAN; OSTEOBLAST; PHYSIOLOGY;

ANIMALS; BONE REMODELING; CELL LINEAGE; HUMANS; MICRORNAS; OSTEOBLASTS; TRANSCRIPTION, GENETIC;

EID: 84948992991     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/ijos.2015.22     Document Type: Review

References (236)

1. Dimitriou R, Jones E, McGonagle D et al. Bone regeneration: current concepts and future directions. BMC Med 2011; 31(9): 66.
2. Siddiqui NA, Owen JM. Clinical advances in bone regeneration. Curr Stem Cell Res Ther 2013; 8(3): 192-200.
3. Tezuka K, Yasuda M, Watanabe N et al. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 2002; 17(2): 231-239.
4. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22(4): 233-241.
5. Hu H, Hilton MJ, Tu X et al. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005; 132(1): 49-60.
6. Estrada K, Styrkarsdottir U, Evangelou E et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012; 44(5): 491-501.
7. Zaidi SK, Young DW, Montecino M et al. Bookmarking the genome: maintenance of epigenetic information. J Biol Chem 2011; 286(21): 18355-18361.
8. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009; 10(2): 94-108.
9. Iorio MV, Piovan C, Croce CM. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta 2010; 1799(10/11/12): 694-701.
10. Sims NA, Gooi JH. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008; 19(5): 444-451.
11. Schaffler MB, Cheung WY, Majeska R et al. Osteocytes: master orchestrators of bone. Calcif Tissue Int 2014; 94(1): 5-24.
12. Kirk MD, Kahn AJ. Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta 1 in osteoblast cell-matrix interaction. J Bone Miner Res 1995; 10(8): 1203-1208.
13. Lien CY, Lee OK, Su Y. Cbfb enhances the osteogenic differentiation of both human and mouse mesenchymal stem cells induced by Cbfa-1 via reducing its ubiquitination mediated degradation. Stem Cells 2007; 25(6): 1462-1468.
14. Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007; 40(2): 251-264.
15. Sims NA, Martin TJ. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep 2014; 3: 481.
16. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008; 319(5871): 1785-1786.
17. Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-297.
18. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006; 13(12): 1097-1101.
19. Kapinas K, Kessler CB, Delany AM. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 2009; 108(1): 216-224.
20. Guo H, Ingolia NT, Weissman JS et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466(7308): 835-840.
21. Ambros V, Chen X. The regulation of genes and genomes by small RNAs. Development 2007; 134(9): 1635-1641.
22. Cullen BR Transcription and processing of human microRNA precursors. Mol Cell 2004; 16(6): 861-865.
23. Bentwich I, Avniel A, Karov Y et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37(7): 766-770.
24. Langenberger D, Çakir MV, Hoffmann S et al. Dicer-processed small RNAs: rules and exceptions. J Exp Zool B Mol Dev Evol 2013; 320(1): 35-46.
25. Dalmay T. Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem 2013; 54(1): 29-38.
26. Titorencu I, Pruna V, Jinga VV et al. Osteoblast ontogeny and implications for bone pathology: an overview. Cell Tissue Res 2014; 355(1): 23-33.
27. Dalle Carbonare L, Innamorati G, Valenti MT. Transcription factor Runx2 and its application to bone tissue engineering. Stem Cell Rev 2012; 8(3): 891-897.
28. Ducy P, Zhang R, Geoffroy V et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89(5): 747-754.
29. Cohen MM Jr. Perspectives on RUNX genes: an update. Am J Med Genet A 2009; 149A(12): 2629-2646.
30. He N, Xiao Z, Yin T et al. Inducible expression of Runx2 results in multiorgan abnormalities in mice. J Cell Biochem 2011; 112(2): 653-665.
31. Ylönen R, Kyrönlahti T, Sund M et al. Type XIII collagen strongly affects bone formation in transgenic mice. J Bone Miner Res 2005; 20(8): 1381-1393.
32. Huszar JM, Payne CJ. MIR146A inhibits JMJD3 expression and osteogenic differentiation in human mesenchymal stem cells. FEBS Lett 2014; 588(9): 1850-1856.
33. Zhang Y, Xie RL, Croce CM et al. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A 2011; 108(24): 9863-9868.
34. Zhang Y, Xie RL, Gordon J et al. Control of mesenchymal lineage progression by microRNAs targeting skeletal gene regulators Trps1 and Runx2. J Biol Chem 2012; 287(26): 21926-21935.
35. Wu T, Zhou H, Hong Y et al. miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 2012; 287(10): 7503-7511.
36. Zaragosi LE, Wdziekonski B, Brigand KL et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 2011; 12(7): R64.
37. Huang J, Zhao L, Xing L et al. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010; 28(2): 357-364.
38. Cui RR, Li SJ, Liu LJ et al. MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc Res 2012; 96(2): 320-329.
39. Mizuno Y, Yagi K, Tokuzawa Y et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 2008; 368(2): 267-272.
40. Huang K, Fu J, Zhou W et al. MicroRNA-125b regulates osteogenic differentiation of mesenchymal stem cells by targeting Cbfß in vitro. Biochimie 2014; 102: 47-55.
41. Chen S, Yang L, Jie Q et al. MicroRNA-125b suppresses the proliferation and osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Mol Med Rep 2014; 9(5): 1820-1826.
42. Pinto MT, Nicolete LD, Rodrigues ES et al. Overexpression of hsa-miR-125b during osteoblastic differentiation does not influence levels of Runx2, osteopontin, and ALPL gene expression. Braz J Med Biol Res 2013; 46(8): 676-680.
43. Wei FL, Wang JH, Ding G et al. Mechanical force-induced specific MicroRNA expression in human periodontal ligament stem cells. Cells Tissues Organs 2014; 199(5/6): 353-363.
44. Chen Y, Mohammed A, Oubaidin M et al. Cyclic stretch and compression forces alter microRNA-29 expression of human periodontal ligament cells. Gene 2015; 566(1): 13-17.
45. Zuo B, Zhu J, Li J et al. microRNA-103a functions as a mechanosensitive microRNA to inhibit bone formation through targeting Runx2. J Bone Miner Res 2015; 30(2): 330-345.
46. Dobreva G, Chahrour M, Dautzenberg M et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 2006; 125(5): 971-986.
47. Zhang J, Tu Q, Grosschedl R et al. Roles of SATB2 in osteogenic differentiation and bone regeneration. Tissue Eng Part A 2011; 17(13/14): 1767-1776.
48. Tang W, Li Y, Osimiri L et al. Osteoblast-specific transcription factor Osterix (Osx)isan upstream regulator of Satb2 during bone formation. J Biol Chem 2011; 286(38): 32995-33002.
49. Conner JR, Hornick JL. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 2013; 63(1): 36-49.
50. Hassan MQ, Gordon JA, Beloti MM et al. A network connecting Runx2, SATB2, and the miR-23a,27a,24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 2010; 107(46): 19879-19884.
51. Park J, Wada S, Ushida T et al. The microRNA-23a has limited roles in bone formation and homeostasis in vivo. Physiol Res 2015. [Epub ahead of print].
52. Wei J, Shi Y, Zheng L et al. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol 2012; 197(4): 509-521.
53. Bae Y, Yang T, Zeng HC et al. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 2012; 21(13): 2991-3000.
54. Deng Y, Bi X, Zhou H et al. Repair of critical-sized bone defects with anti-miR-31-expressing bone marrow stromal stem cells and poly(glycerol sebacate) scaffolds. Eur Cell Mater 2014; 27: 13-24; discussion 24-25
55. Xie Q, Wang Z, Bi X et al. Effects of miR-31 on the osteogenesis of human mesenchymal stem cells. Biochem Biophys Res Commun 2014; 446(1): 98-104.
56. Deng Y, Wu S, Zhou H et al. Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells. Stem Cells Dev 2013; 22(16): 2278-2286.
57. Chen S, Feng J, Zhang H et al. Key role for the transcriptional factor, Osterix, in spine development. Spine J 2014; 14(4): 683-694.
58. Nakashima K, Zhou X, Kunkel G et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108(1): 17-29.
59. Nishio Y, Dong Y, Paris M et al. Runx2-mediated regulation of the zinc finger Osterix/ Sp7 gene. Gene 2006; 372: 62-70.
60. Celil AB, Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 2005; 280(36): 31353-31359.
61. Matsubara T, Kida K, Yamaguchi A et al. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 2008; 283(43): 29119-29125.
62. Baglìo SR, Devescovi V, Granchi D et al. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene 2013; 527(1): 321-331.
63. Yang L, Cheng P, Chen C et al. miR-93/Sp7 function loop mediates osteoblast mineralization. J Bone Miner Res 2012; 27(7): 1598-1606.
64. Li E, Zhang J, Yuan T et al. MiR-143 suppresses osteogenic differentiation by targeting Osterix. Mol Cell Biochem 2014; 390(1/2): 69-74.
65. Jia J, Tian Q, Ling S et al. miR-145 suppresses osteogenic differentiation by targeting Sp7. FEBS Lett 2013; 587(18): 3027-3031.
66. Liu H, Lin H, Zhang L et al. miR-145 and miR-143 regulate odontoblast differentiation through targeting Klf4 and Osx genes in a feedback loop. J Biol Chem 2013; 288(13): 9261-9271.
67. Zhang JF, Fu WM, He ML et al. MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell 2011; 22(21): 3955-3961.
68. Shi K, Lu J, Zhao Y et al. MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix. Bone 2013; 55(2): 487-494.
69. Gámez B, Rodríguez-Carballo E, Bartrons R et al. MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability. J Biol Chem 2013; 288(20): 14264-14275.
70. Chen Q, Liu W, Sinha KM et al. Identification and characterization of microRNAs controlled by the osteoblast-specific transcription factor Osterix. PLoS One 2013; 8(3): e58104.
71. Chen G, Deng C, Li YP. TGF-ß and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8(2): 272-288.
72. Song B, Estrada KD, Lyons KM. Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev 2009; 20(5/6): 379-388.
73. Afzal F, Pratap J, Ito K et al. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol 2005; 204(1): 63-72.
74. Kureel J, Dixit M, Tyagi AM et al. miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation. Cell Death Dis 2014; 5: e1050.
75. Luzi E, Marini F, Sala SC et al. Osteogenic differentiation of human adipose tissue derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 2008; 23(2): 287-295.
76. Xu S, Cecilia Santini G, De Veirman K et al. Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients. PLoS One 2013; 8(11): e79752.
77. Li Z, Hassan MQ, Volinia S et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 2008; 105(37): 13906-13911.
78. Schaap-Oziemlak AM, Raymakers RA, Bergevoet SM et al. MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev 2010; 19(6): 877-885.
79. Li H, Li T, Wang S et al. miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res 2013; 10(3): 313-324.
80. Zeng Y, Qu X, Li H et al. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett 2012; 586(16): 2375-2381.
81. Hwang S, Park SK, Lee HY et al. miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett 2014; 588(17): 2957-2963.
82. Jia J, Feng X, Xu W et al. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Exp Mol Med 2014; 46: e107.
83. Liu T, Fu NN, Song HL et al. Suppression of MicroRNA-203 improves survival of rat bone marrow mesenchymal stem cells through enhancing PI3K-induced cellular activation. IUBMB Life 2014; doi: 10.1002/iub.1259. [Epub ahead of print].
84. Day TF, Guo X, Garrett-Beal L et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005; 8(5): 739-750.
85. Rossini M, Gatti D, Adami S. Involvement of WNT/b-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 2013; 93(2): 121-132.
86. Liu G, Vijayakumar S, Grumolato L et al. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol 2009; 185(1): 67-75.
87. Liu W, Liu Y, Guo T et al. TCF3, a novel positive regulator of osteogenesis, plays a crucial role in miR-17 modulating the diverse effect of canonical Wnt signaling in different microenvironments. Cell Death Dis 2013; 4: e539.
88. Roberto VP, Tiago DM, Silva IA et al. MiR-29a is an enhancer of mineral deposition in bone-derived systems. Arch Biochem Biophys 2014; 564: 173-183.
89. Gaur T, Lengner CJ, Hovhannisyan H et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005; 280(39): 33132-33140.
90. Wang J, Guan X, Guo F et al. miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor related protein 6. Cell Death Dis 2013; 4: e845.
91. Qiu W, Kassem M. miR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation. Biochim Biophys Acta 2014; 1843(9): 2114-2121.
92. Yang X, Matsuda K, Bialek P et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004; 117(3): 387-398.
93. Makowski AJ, Uppuganti S, Wadeer SA et al. The loss of activating transcription factor 4 (ATF4) reduces bone toughness and fracture toughness. Bone 2014; 62: 1-9.
94. Xiao G, Jiang D, Ge C et al. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem 2005; 280(35): 30689-30696.
95. Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev 2013; 19(3): 254-263.
96. St-Arnaud R, Mandic V. FIAT control of osteoblast activity. J Cell Biochem 2010; 109(3): 453-459.
97. St-Arnaud R, Hekmatnejad B. Combinatorial control of ATF4-dependent gene transcription in osteoblasts. Ann N Y Acad Sci 2011; 1237: 11-18.
98. Hekmatnejad B, Gauthier C, St-Arnaud R. Control of Fiat (factor inhibiting ATF4 mediated transcription) expression by Sp family transcription factors in osteoblasts. J Cell Biochem 2013; 114(8): 1863-1870.
99. Matsuguchi T, Chiba N, Bandow K et al. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation. J Bone Miner Res 2009; 24(3): 398-410.
100. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 2008; 9: 183-196.
101. Wang X, Guo B, Li Q et al. miR-214 targets ATF4 to inhibit bone formation. Nat Med 2013; 19(1): 93-100.
102. Byun MR, Kim AR, Hwang JH et al. FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression. Bone 2014; 58: 72-80.
103. Byun MR, Hwang JH, Kim AR et al. Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation. Cell Death Differ 2014; 21(6): 854-863.
104. Byun MR, Kim AR, Hwang JH et al. Phorbaketal A stimulates osteoblast differentiation through TAZ mediated Runx2 activation. FEBS Lett 2012; 586(8): 1086-1092.
105. Jang EJ, Jeong H, Kang JO et al. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ. Br J Pharmacol 2012; 165(5): 1584-1594.
106. Hong JH, Hwang ES, McManus MT et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005; 309(5737): 1074-1078.
107. Hong JH, Yaffe MB. TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 2006; 5(2): 176-179.
108. Cho HH, Shin KK, Kim YJ et al. NF-kB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 2010; 223(1): 168-177.
109. Chaulk SG, Lattanzi VJ, Hiemer SE et al. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. J Biol Chem 2014; 289(4): 1886-1891.
110. Hao J, Zhang Y, Jing D et al. Role of Hippo signaling in cancer stem cells. J Cell Physiol 2014; 229(3): 266-270.
111. Dupont S, Morsut L, Aragona M et al. Role of YAP/TAZ in mechanotransduction. Nature 2011; 474(7350): 179-183.
112. Hao J, Zhang Y, Wang Y et al. Role of extracellular matrix and YAP/TAZ in cell fate determination. Cell Signal 2014; 26(2): 186-191.
113. Eskildsen T, Taipaleenmäki H, Stenvang J et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A 2011; 108(15): 6139-6144.
114. Qu B, Xia X, Wu HH et al. PDGF-regulated miRNA-138 inhibits the osteogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2014; 448(3): 241-247.
115. Guan X, Gao Y, Zhou J et al. miR-223 regulates adipogenic and osteogenic differentiation of mesenchymal stem cells through a C/EBPs/miR-223/FGFR2 regulatory feedback loop. Stem Cells 2015; 33(5): 1589-1600.
116. Liu H, Sun Q, Wan C et al. MicroRNA-338-3p regulates osteogenic differentiation of mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2. J Cell Physiol 2014; 229(10): 1494-1502.
117. Lecanda F, Warlow PM, Sheikh S et al. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 2000; 151(4): 931-944.
118. Kim HK, Lee YS, Sivaprasad U et al. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006; 174(5): 677-687.
119. Inose H, Ochi H, Kimura A et al. A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A 2009; 106(49): 20794-20799.
120. Itoh T, Nozawa Y, Akao Y. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 2009; 284(29): 19272-19279.
121. Sangani R, Periyasamy-Thandavan S, Kolhe R et al. MicroRNAs-141 and 200a regulate the SVCT2 transporter in bone marrow stromal cells. Mol Cell Endocrinol 2015; 410: 19-26.
122. Okamoto H, Matsumi Y, Hoshikawa Y et al. Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells. PLoS One 2012; 7(8): e43800.
123. Qadir AS, Um S, Lee H et al. miR-124 negatively regulates osteogenic differentiation and in vivo bone formation of mesenchymal stem cells. J Cell Biochem 2015; 116(5): 730-742.
124. Tyagi S, Gupta P, Saini AS et al. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res 2011; 2(4): 236-240.
125. James AW Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica: Cairo 2013; 2013: 684736.
126. Sethi JK, Vidal-Puig AJ. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 2007; 48(6): 1253-1262.
127. Akune T, Ohba S, Kamekura S et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004; 113(6): 846-855.
128. Jeon MJ, Kim JA, Kwon SH et al. Activation of peroxisome proliferator-activated receptor-c inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 2003; 278(26): 23270-23277.
129. Liu J, Wang H, Zuo Y et al. Functional interaction between peroxisome proliferator activated receptor γ and β-catenin. Mol Cell Biol 2006; 26(15): 5827-5837.
130. Zhao QH, Wang SG, Liu SX et al. PPARc forms a bridge between DNA methylation and histone acetylation at the C/EBPa gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells. FEBS J 2013; 280(22): 5801-5814.
131. Kang Q, Song WX, Luo Q et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009; 18(4): 545-559.
132. Sun J, Wang Y, Li Y et al. Downregulation of PPARc by miR-548d-5p suppresses the adipogenic differentiation of human bone marrow mesenchymal stem cells and enhances their osteogenic potential. J Transl Med 2014; 12: 168.
133. He J, Zhang JF, Yi C et al. miRNA-mediated functional changes through co-regulating function related genes. PLoS One 2010; 5(10): e13558.
134. Zhang JF, Fu WM, He ML et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol 2011; 8(5): 829-838.
135. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006; 25(57): 7469-7481.
136. Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 2007; 13(14): 4042-4045.
137. Zhang WB, Zhong WJ, Wang L. A signal-amplification circuit between miR-218 and Wnt/b-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation. Bone 2014; 58: 59-66.
138. Hassan MQ, Maeda Y, Taipaleenmaki H et al. miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem 2012; 287(50): 42084-42092.
139. Zhang J, Tu Q, Bonewald LF et al. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res 2011; 26(8): 1953-1963.
140. van Rooij E, Sutherland LB, Thatcher JE et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105(35): 13027-13032.
141. Li Z, Hassan MQ, Jafferji M et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009; 284(23): 15676-15684.
142. Egea V, Zahler S, Rieth N et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/b-catenin signaling. Proc Natl Acad Sci U S A 2012; 109(6): E309-E316.
143. Wang T, Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun 2010; 402(2): 186-189.
144. Guo D, Li Q, Lv Q et al. MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation. PLoS One 2014; 9(3): e91354.
145. Jensen ED, Nair AK, Westendorf JJ. Histone deacetylase co-repressor complex control of Runx2 and bone formation. Crit Rev Eukaryot Gene Expr 2007; 17(3): 187-196.
146. Jeon EJ, Lee KY, Choi NS et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem 2006; 281(24): 16502-16511.
147. Kang JS, Alliston T, Delston R et al. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J 2005; 24(14): 2543-2555.
148. Liu T, Hou L, Zhao Y et al. Epigenetic silencing of HDAC1 by miR-449a upregulates Runx2 and promotes osteoblast differentiation. Int J Mol Med 2015; 35(1): 238-246.
149. Trompeter HI, Dreesen J, Hermann E et al. MicroRNAs miR-26a, miR-26b, and miR29b accelerate osteogenic differentiation of unrestricted somatic stem cells from human cord blood. BMC Genomics 2013; 14: 111.
150. Li H, Xie H, Liu W et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009; 119(12): 3666-3677.
151. Hu R, Liu W, Li H et al. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 2011; 286(14): 12328-12339.
152. Zhang Y, Kwon S, Yamaguchi T et al. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 2008; 28(5): 1688-1701.
153. Huang S, Wang S, Bian C et al. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev 2012; 21(13): 2531-2540.
154. Li CJ, Cheng P, Liang MK et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest 2015; 125(4): 1509-1522.
155. Bakhshandeh B, Hafizi M, Ghaemi N et al. Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells. Biotechnol Lett 2012; 34(8): 1579-1587.
156. Bhushan R, Grünhagen J, Becker J et al. miR-181a promotes osteoblastic differentiation through repression of TGF-b signaling molecules. Int J Biochem Cell Biol 2013; 45(3): 696-705.
157. Mizuno Y, Tokuzawa Y, Ninomiya Y et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 2009; 583(13): 2263-2268.
158. Cheung KS, Sposito N, Stumpf PS et al. MicroRNA-146a regulates human foetal femur derived skeletal stem cell differentiation by down-regulating SMAD2 and SMAD3. PLoS One 2014; 9(6): e98063.
159. Vimalraj S, Partridge NC, Selvamurugan N. A positive role of microRNA-15b on regulation of osteoblast differentiation. J Cell Physiol 2014; 229(9): 1236-1244.
160. Grünhagen J, Bhushan R, Degenkolbe E et al. MiR-497-195 cluster microRNAs regulate osteoblast differentiation by targeting BMP signaling. J Bone Miner Res 2015; 30(5): 796-808.
161. Jeong BC, Kang IH, Hwang YC et al. MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression. Cell Death Dis 2014; 5: e1532.
162. Kang IH, Jeong BC, Hur SW et al. MicroRNA-302a stimulates osteoblastic differentiation by repressing COUP-TFII expression. J Cell Physiol 2015; 230(4): 911-921.
163. Yang M, Pan Y, Zhou Y. miR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells. FEBS Lett 2014; 588(24): 4761-4768.
164. Yu S, Geng Q, Ma J et al. Heparin-binding EGF-like growth factor and miR-1192 exert opposite effect on Runx2-induced osteogenic differentiation. Cell Death Dis 2013; 4: e868.
165. Meng YB, Li X, Li ZY et al. microRNA-21 promotes osteogenic differentiation of mesenchymal stem cells by the PI3K/b-catenin pathway. J Orthop Res 2015; 33(7): 957-964.
166. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2(4): 389-406.
167. Del Fattore A, Teti A, Rucci N. Osteoclast receptors and signaling. Arch Biochem Biophys 2008; 473(2): 147-160.
168. Mizoguchi F, Izu Y, Hayata T et al. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem 2010; 109(5): 866-875.
169. Sugatani T, Hildreth BE 3rd, Toribio RE et al. Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity. J Cell Biochem 2014; 115(6): 1043-1047.
170. Boyce BF Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res 2013; 92(10): 860-867.
171. Boyce BF Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. J Bone Miner Res 2013; 28(4): 711-722.
172. Liu T, Qin AP, Liao B et al. A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3). Bone 2014; 67: 156-165.
173. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007; 9(Suppl 1): S1.
174. Chen C, Cheng P, Xie H et al. MiR-503 regulates osteoclastogenesis via targeting RANK. J Bone Miner Res 2014; 29(2): 338-347.
175. Guo LJ, Liao L, Yang L et al. MiR-125a TNF receptor-associated factor 6 to inhibit osteoclastogenesis. Exp Cell Res 2014; 321(2): 142-152.
176. Lee Y, Kim HJ, Park CK et al. MicroRNA-124 regulates osteoclast differentiation. Bone 2013; 56(2): 383-389.
177. Mizoguchi F, Murakami Y, Saito T et al. miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis Res Ther 2013; 15(5): R102.
178. Chellaiah MA, Soga N, Swanson S et al. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 2000; 275(16): 11993-12002.
179. Takayanagi H, Kim S, Matsuo K et al. RANKL maintains bone homeostasis through cFos-dependent induction of interferon-beta. Nature 2002; 416(6882): 744-749.
180. Grigoriadis AE, Wang ZQ, Cecchini MG et al. c-Fos: a key regulator of osteoclast macrophage lineage determination and bone remodeling. Science 1994; 266 (5184): 443-448.
181. Sugatani T, Vacher J, Hruska KA. A microRNA expression signature of osteoclasto genesis. Blood 2011; 117(13): 3648-3657.
182. Zhou Y, Liu Y, Cheng L. miR-21 expression is related to particle-induced osteolysis pathogenesis. J Orthop Res 2012; 30(11): 1837-1842.
183. Sugatani T, Hruska KA. Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis. J Cell Biochem 2013; 114(6): 1217-1222.
184. Kim K, Kim JH, Lee J et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 2007; 109(8): 3253-3259.
185. Takigawa M. CCN2: a master regulator of the genesis of bone and cartilage. J Cell Commun Signal 2013; 7(3): 191-201.
186. Kim K, Kim JH, Kim I et al. MicroRNA-26a regulates RANKL-induced osteoclast formation. Mol Cells 2015; 38(1): 75-80.
187. Sato K, Takayanagi H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 2006; 18(4): 419-426.
188. Blüml S, Bonelli M, Niederreiter B et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum 2011; 63(5): 1281-1288.
189. Li YT, Chen SY, Wang CR et al. Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223. Arthritis Rheum 2012; 64(10): 3240-3245.
190. Sugatani T, Hruska KA. MicroRNA-223 is a key factor in osteoclast differentiation. J Cell Biochem 2007; 101(4): 996-999.
191. Shibuya H, Nakasa T, Adachi N et al. Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation. Mod Rheumatol 2013; 23(4): 674-685.
192. Pauley KM, Cha S. miRNA-146a in rheumatoid arthritis: a new therapeutic strategy. Immunotherapy 2011; 3(7): 829-831.
193. Pauley KM, Satoh M, Chan AL et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008; 10(4): R101.
194. Nakasa T, Miyaki S, Okubo A et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008; 58(5): 1284-1292.
195. Zhao Q, Shao J, Chen W et al. Osteoclast differentiation and gene regulation. Front Biosci 2007; 12: 2519-2529.
196. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004; 14(11): 628-638.
197. Mellis DJ, Itzstein C, Helfrich MH et al. The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption. J Endocrinol 2011; 211(2): 131-143.
198. vβ and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 2005; 208: 88-105.
199. Kitaura H, Kimura K, Ishida M et al. Effect of cytokines on osteoclast formation and bone resorption during mechanical force loading of the periodontal membrane. Sci World J 2014; 2014: 617032.
200. Zhao C, Sun W, Zhang P et al. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol 2015; 12(3): 343-353.
201. Osta B, Benedetti G, Miossec P. Classical and paradoxical effects of TNF-α on bone homeostasis. Front Immunol 2014; 5: 48.
202. 3/Pebp2αA) is inhibited by tumor necrosis factor-α. J Biol Chem 2002; 277(4): 2695-2701.
203. Huang H, Zhao N, Xu X et al. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Prolif 2011; 44(5): 420-427.
204. Gilbert LC, Chen H, Lu X et al. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts. Bone 2013; 56(1): 174-183.
205. Hah YS, Kang HG, Cho HY et al. JNK signaling plays an important role in the effects of TNF-α and IL-1β on in vitro osteoblastic differentiation of cultured human periosteal derived cells. Mol Biol Rep 2013; 40(8): 4869-4881.
206. Mukai T, Otsuka F, Otani H et al. TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun 2007; 356(4): 1004-1010.
207. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987; 138(3): 775-779.
208. Kitaura H, Kimura K, Ishida M et al. Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo. Clin Dev Immunol 2013; 2013: 181-849.
209. Kohara H, Kitaura H, Fujimura Y et al. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol Lett 2011; 137(1/2): 53-61.
210. Wu T, Xie M, Wang X et al. miR-155 modulates TNF-a-inhibited osteogenic differentiation by targeting SOCS1 expression. Bone 2012; 51(3): 498-505.
211. Zhang J, Zhao H, Chen J et al. Interferon-b-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett 2012; 586(19): 3255-3262.
212. Kagiya T, Nakamura S. Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation. J Periodont Res 2013; 48(3): 373-385.
213. Yang N, Wang G, Hu C et al. Tumor necrosis factor a suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res 2013; 28(3): 559-573.
214. Dong J, Cui X, Jiang Z et al. MicroRNA-23a modulates tumor necrosis factor-alpha induced osteoblasts apoptosis by directly targeting Fas. J Cell Biochem 2013; 114(12): 2738-2745.
215. Mead TJ, Yutzey KE. Notch signaling and the developing skeleton. Adv Exp Med Biol 2012; 727: 114-130.
216. Hilton MJ, Tu X, Wu X et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 2008; 14(3): 306-314.
217. Engin F, Yao Z, Yang T et al. Dimorphic effects of Notch signaling in bone homeostasis. Nat Med 2008; 14(3): 299-305.
218. Yamada T, Yamazaki H, Yamane T et al. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood 2003; 101(6): 2227-2234.
219. Chen L, Holmstrøm K, Qiu W et al. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells 2014; 32(4): 902-912.
220. Krzeszinski JY, Wei W, Huynh H et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature 2014; 512(7515): 431-435.
221. Palmieri A, Pezzetti F, Brunelli G et al. Differences in osteoblast miRNA induced by cell binding domain of collagen and silicate-based synthetic bone. J Biomed Sci 2007; 14(6): 777-782.
222. Annalisa P, Furio P, Ilaria Z et al. Anorganic bovine bone and a silicate-based synthetic bone activate different microRNAs. J Oral Sci 2008; 50(3): 301-307.
223. Deng Y, Zhou H, Gu P et al. Repair of canine medial orbital bone defects with miR-31-modified bone marrow mesenchymal stem cells. Invest Ophthalmol Vis Sci 2014; 55(9): 6016-6023.
224. Wang Y, Jiang XL, Yang SC et al. MicroRNAs in the regulation of interfacial behaviors of MSCs cultured on microgrooved surface pattern. Biomaterials 2011; 32(35): 9207-9217.
225. Wu K, Song W, Zhao L et al. MicroRNA functionalized microporous titanium oxide surface by lyophilization with enhanced osteogenic activity. ACS Appl Mater Interfaces 2013; 5(7): 2733-2744.
226. Wu K, Xu J, Liu M et al. Induction of osteogenic differentiation of stem cells via a lyophilized microRNA reverse transfection formulation on a tissue culture plate. Int J Nanomedicine 2013; 8: 1595-1607.
227. Suh JS, Lee JY, Choi YS et al. Peptide-mediated intracellular delivery of miRNA-29b for osteogenic stem cell differentiation. Biomaterials 2013; 34(17): 4347-4359.
228. Qureshi AT, Monroe WT, Dasa V et al. miR-148b-nanoparticle conjugates for light mediated osteogenesis of human adipose stromal/stem cells. Biomaterials 2013; 34(31): 7799-7810.
229. Liu J, Dang L, Li D et al. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts. Biomaterials 2015; 52: 148-160.
230. 2/2 mice. Cardiovasc Res 2015; 106(1): 131-142.
231. Wei J, Li H, Wang S et al. let-7 enhances osteogenesis and bone formation while repressing adipogenesis of human stromal/mesenchymal stem cells by regulating HMGA2. Stem Cells Dev 2014; 23(13): 1452-1463.
232. Trohatou O, Zagoura D, Bitsika V et al. Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med 2014; 3(1): 54-68.
233. Li J, He X, Wei W et al. MicroRNA-194 promotes osteoblast differentiation via downregulating STAT1. Biochem Biophys Res Commun 2015; 460(2): 482-488.
234. Kim YJ, Bae SW, Yu SS et al. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 2009; 24(5): 816-825.
235. Guo J, Ren F, Wang Y et al. miR-764-5p promotes osteoblast differentiation through inhibition of CHIP/STUB1 expression. J Bone Miner Res 2012; 27(7): 1607-1618.
236. Dou C, Zhang C, Kang F et al. MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation. Biochim Biophys Acta 2014; 1839(11): 1084-1096.